Anti-HMGB1 antibody also reduced BALF levels of endothelin-1 (Fig. 3B), a potent vasoconstricting and mitogenic factor for smooth muscle cells and a well-established therapeutic target for PAH. The gene discussed is EDN1; the disease is pulmonary arterial hypertension.